Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Drug crawled time : 21:00 save search
Vertex Announces FDA Clearance of Investigational New Drug Application for VX-407 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Published: 2024-03-21 (Crawled : 21:00) - biospace.com/
VRTX | $404.015 1.02% 120K
|
Health Technology
|
| O: 0.85%
H: 0.88%
C: 0.02%
vx-407 fda drug disease kidney treatment clearance application
NVIDIA Healthcare Launches Generative AI Microservices to Advance Drug Discovery, MedTech and Digital Health
Published: 2024-03-18 (Crawled : 21:00) - globenewswire.com
NVDA | News | $810.86 1.97% 8.6M
|
Electronic Technology
|
| O: -1.98%
H: 4.43%
C: 3.11%
drug health nvidia
Corvus Pharmaceuticals Announces Orphan Drug Designation Granted to Soquelitinib for the Treatment of T Cell Lymphoma
Published: 2024-02-08 (Crawled : 21:00) - globenewswire.com
CRVS | $1.44 29K
|
Health Technology
|
| O: 9.0%
H: 18.35%
C: 1.61%
drug granted cell treatment pharmaceuticals designation
Amneal Announces Complete Response Resubmission for IPX203 New Drug Application
Published: 2024-02-08 (Crawled : 21:00) - globenewswire.com
AMRX | $5.455 1.58% 39K
|
Health Technology
|
| O: 0.18%
H: 1.83%
C: 1.83%
ipx203 drug resubmission application response
U.S. Food and Drug Administration Grants Full Approval for BALVERSA® to Treat Locally Advanced or Metastatic Bladder Cancer with Select Genetic Alterations
Published: 2024-01-19 (Crawled : 21:00) - prnewswire.com
JNJ | News | $148.88 -0.16% 940K
|
Health Technology
| Email alert
Add to watchlist
balversa drug genetic approval food bladder cancer treat grants advanced
Federal Court Allows Vanda Pharmaceuticals' Lawsuit to Proceed Against the U.S. Food and Drug Administration
Published: 2024-01-19 (Crawled : 21:00) - prnewswire.com
VNDA | $4.855 1.15% 160K
|
Health Technology
| Email alert
Add to watchlist
drug food
CRISPR Therapeutics Announces U.S. Food and Drug Administration (FDA) Approval of CASGEVY™ (exagamglogene autotemcel) for the Treatment of Transfusion-Dependent Beta Thalassemia
Published: 2024-01-16 (Crawled : 21:00) - globenewswire.com
VRTX | $404.015 1.02% 120K
|
Health Technology
|
| O: 0.0%
H: 0.52%
C: -0.85%
CRSP | News M | $57.775 3.8% 230K
|
Health Technology
|
| O: -1.86%
H: 1.36%
C: -2.23%
drug crispr approval food treatment therapeutics
Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncology
Published: 2024-01-03 (Crawled : 21:00) - globenewswire.com
GLPG | News | $29.18 0.38% 6K
|
Health Technology
|
| O: 0.8%
H: 0.7%
C: -0.22%
drug collaboration
Innocan Pharma Announces Expert Team for LPT CBD Application to United States Food and Drug Administration
Published: 2023-12-12 (Crawled : 21:00) - prnewswire.com
JNJ | News | $148.88 -0.16% 940K
|
Health Technology
|
| O: -0.71%
H: 0.0%
C: 0.0%
pharma drug food cbd application
Neurocrine Biosciences Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Crinecerfont in Congenital Adrenal Hyperplasia
Published: 2023-12-05 (Crawled : 21:00) - prnewswire.com
NBIX | News M | $141.575 5.92% 390K
|
Health Technology
|
| O: 0.39%
H: 1.01%
C: 0.39%
drug food designation therapy
Harrow Completes Transfer of the TRIESENCE® New Drug Application
Published: 2023-11-29 (Crawled : 21:00) - biospace.com/
HROW P | $10.81 1.98% 22K
|
Health Technology
|
| O: 1.33%
H: 3.95%
C: -1.43%
triesence drug transfer application
Hepion Pharmaceuticals to Present at the 7th Obesity & NASH Drug Development Summit
Published: 2023-11-28 (Crawled : 21:00) - globenewswire.com
HEPA | $1.39 -1.42% 9.8K
|
Health Technology
|
| O: 0.33%
H: 2.25%
C: -1.77%
obesity drug pharmaceuticals nash
XPHOZAH® (tenapanor) Granted Orphan Drug Designation by U.S. FDA for the Treatment of Pediatric Hyperphosphatemia
Published: 2023-11-15 (Crawled : 21:00) - globenewswire.com
ARDX | $6.6 1.38% 140K
|
Health Technology
|
| O: 0.78%
H: 3.72%
C: 3.33%
xphozah fda drug granted treatment designation hyperphosphatemia
Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC291, a Hypoimmune-modified, CD19-directed Allogeneic CAR T Therapy, for Patients with Lupus Nephritis, Extrarenal Lupus, and ANCA-associated Vasculitis
Published: 2023-11-09 (Crawled : 21:00) - globenewswire.com
SANA | $8.225 3.72% 430K
|
|
| O: 1.06%
H: 0.9%
C: 0.9%
sc291 fda drug lupus clearance application
Lyell Immunopharma Receives FDA Orphan Drug Designation for LYL845 for the Treatment of Melanoma
Published: 2023-11-09 (Crawled : 21:00) - globenewswire.com
LYEL | $2.485 3.11% 63K
|
Professional, Scientific, and T...
|
| O: -1.37%
H: 0.0%
C: -23.38%
lyl845 fda melanoma drug treatment designation
CytomX Therapeutics Presents Preclinical Profile of EpCAM-directed Antibody Drug Conjugate CX-2051 at 2023 World ADC Conference
Published: 2023-10-18 (Crawled : 21:00) - globenewswire.com
CTMX | $1.725 3.29% 30K
|
Health Technology
|
| O: 0.75%
H: 4.44%
C: -0.74%
cx-2051 drug conference antibody world preclinical therapeutics
Cassava Sciences Announces Science Publication That Confirms Mechanism of Action of Simufilam, a Novel Drug Candidate for People with Alzheimer’s Disease
Published: 2023-09-13 (Crawled : 21:00) - globenewswire.com
SAVA M | $20.76 1.27% 45K
|
Health Technology
|
| O: 0.77%
H: 4.73%
C: 0.0%
drug candidate disease alzheimer’s publication sciences
Daré Bioscience to Present at the 9th Annual International Symposium of Drug Delivery Systems
Published: 2023-07-11 (Crawled : 21:00) - globenewswire.com
DARE | $0.2953 120K
|
Health Technology
|
| O: 1.64%
H: 0.0%
C: -0.56%
drug symposium bioscience international
Zenocutuzumab (Zeno) granted Breakthrough Therapy Designation by the U.S. Food & Drug Administration for the treatment of NRG1+ pancreatic cancer
Published: 2023-06-29 (Crawled : 21:00) - globenewswire.com
MRUS | $41.51 2.62% 20K
|
Health Technology
|
| O: 0.68%
H: 1.81%
C: -0.49%
drug granted food cancer pancreatic treatment designation therapy
SPAC Phoenix Biotech to merge with immunology drug developer … – Seeking Alpha
Published: 2023-06-05 (Crawled : 21:00) - spacfeed.com
SKWD | $37.0 1.29% 8.2K
|
|
| O: -2.89%
H: 13.43%
C: 2.62%
drug biotech spac immunology merge
Gainers vs Losers
| 85% | 15% |
Top 10 Gainers
MTTR | News M | $4.625 165.81% 5.5M
|
AGBA | $2.46 96.8% 28M
|
Finance
EDBL | News | $6.94 84.57% 1.4M
|
CZOO | $7.74 55.11% 2.7M
|
PALI | $7.64 54.97% 14M
|
Manufacturing
OPRT | News | $3.19 41.78% 3M
|
Finance
PEGY | $0.0629 37.34% 110M
|
Manufacturing
ZAPP | $6.02 35.59% 95K
|
n/a
MLEC | $1.87 33.57% 1.6M
|
n/a
ATGL | $3.66 27.97% 150K
|
Your saved searches
Save your searches and get alerts when important news are released.